315 related articles for article (PubMed ID: 31717302)
1. Combination Radioimmunotherapy Strategies for Solid Tumors.
Zaheer J; Kim H; Lee YJ; Kim JS; Lim SM
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717302
[TBL] [Abstract][Full Text] [Related]
2. B7-H3-targeted Radioimmunotherapy of Human Cancer.
Kasten BB; Ferrone S; Zinn KR; Buchsbaum DJ
Curr Med Chem; 2020; 27(24):4016-4038. PubMed ID: 30836909
[TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
4. Combination Radioimmunotherapy Approaches and Quantification of Immuno-PET.
Kim JS
Nucl Med Mol Imaging; 2016 Jun; 50(2):104-11. PubMed ID: 27275358
[TBL] [Abstract][Full Text] [Related]
5. Emerging trends for radioimmunotherapy in solid tumors.
Jain M; Gupta S; Kaur S; Ponnusamy MP; Batra SK
Cancer Biother Radiopharm; 2013 Nov; 28(9):639-50. PubMed ID: 23844555
[TBL] [Abstract][Full Text] [Related]
6. Clinical radioimmunotherapy.
Knox SJ; Meredith RF
Semin Radiat Oncol; 2000 Apr; 10(2):73-93. PubMed ID: 10727597
[TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of cancer: using monoclonal antibodies to target radiotherapy.
Illidge TM; Brock S
Curr Pharm Des; 2000 Sep; 6(14):1399-418. PubMed ID: 10903400
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?
Sautter-Bihl ML; Bihl H
Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292
[TBL] [Abstract][Full Text] [Related]
9. [Radiolabeled antibodies for cancer treatment].
Barbet J; Chatal JF; Kraeber-Bodéré F
Med Sci (Paris); 2009 Dec; 25(12):1039-45. PubMed ID: 20035676
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.
Ma D; McDevitt MR; Barendswaard E; Lai L; Curcio MJ; Pellegrini V; Brechbiel MW; Scheinberg DA
Leukemia; 2002 Jan; 16(1):60-6. PubMed ID: 11840264
[TBL] [Abstract][Full Text] [Related]
11. Strategies for developing effective radioimmunotherapy for solid tumors.
DeNardo GL; O'Donnell RT; Kroger LA; Richman CM; Goldstein DS; Shen S; DeNardo SJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3219s-3223s. PubMed ID: 10541367
[TBL] [Abstract][Full Text] [Related]
12. Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
van Gog FB; Brakenhoff RH; Stigter-van Walsum M; Snow GB; van Dongen GA
Int J Cancer; 1998 Jul; 77(1):13-8. PubMed ID: 9639387
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.
Martins CD; Kramer-Marek G; Oyen WJG
Expert Opin Drug Deliv; 2018 Feb; 15(2):185-196. PubMed ID: 28893110
[TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
Kelly MP; Lee FT; Smyth FE; Brechbiel MW; Scott AM
J Nucl Med; 2006 Apr; 47(4):716-25. PubMed ID: 16595507
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
16. The new golden era for radioimmunotherapy: not just for lymphomas anymore.
Tomblyn MB; Katin MJ; Wallner PE
Cancer Control; 2013 Jan; 20(1):60-71. PubMed ID: 23302908
[TBL] [Abstract][Full Text] [Related]
17. Antibody-guided radiation therapy of cancer.
Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
[TBL] [Abstract][Full Text] [Related]
18. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
[TBL] [Abstract][Full Text] [Related]
19. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
Crow DM; Williams L; Colcher D; Wong JY; Raubitschek A; Shively JE
Bioconjug Chem; 2005; 16(5):1117-25. PubMed ID: 16173788
[TBL] [Abstract][Full Text] [Related]
20. Intracavitary radioimmunotherapy to treat solid tumors.
Aarts F; Bleichrodt RP; Oyen WJ; Boerman OC
Cancer Biother Radiopharm; 2008 Feb; 23(1):92-107. PubMed ID: 18298333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
